Israel Parkinson is a unique initiative of The Aufzien Family Center for Prevention and Treatment of Parkinson's Disease at the Tel Aviv University, developed to create a database of historical and current information for research and public health purposes.

By participating in this project you will help us greatly to gather important and meaningful data to reach our final goal - cure for Parkinson! 

Join us now and you will support: 

Investigating risk factors for Parkinson's Diseases

Explore the genetic fingerprint of the disease

The understanding of cognitive, autonomic and affective signs and symptoms of the prodromal phase (before diagnosis) 

And more...

The highest data security measures are in place to assure the privacy and confidentiality of your information

JOIN US NOW

The Aufzien Family Center for the Prevention and Treatment of Parkinson's Disease (APPD) has been established by a generous donation from the Aufzien Family to promote and enhance research towards better treatment and prevention of Parkinson's Disease. The APPD is an academic Center at The Faculty of Medicine and Sagol School of Neuroscience at Tel Aviv University, which serves as a hub for innovative translational research in Parkinson's Disease. The center has a grant program and educational activities to support cutting-edge research towards better treatment and prevention, or slowing down of Parkinson's Disease progression. The Center holds monthly seminars, annual international symposiums and active student exchange programs and promotes Parkinson’s research conducted on campus and at affiliated hospitals, working toward the development of novel drugs, therapies and diagnostic technologies for Parkinson’s Disease.

Israel Parkinson is led by a Steering Committee, composed of the Israeli Movement Disorders Society steering committee members (IMDS, part of the Israel Neurological Association), who are leading experts in the field of movement disorders and the directors of the Aufzien Center. The Steering Committee provides strategic direction, support, guidance and oversight of the Israel Parkinson Initiative.

The current Chairman of the Israel Parkinson Steering Committee is Prof. Nir Giladi.

Members of the Steering Committee

Nir Giladi, M.D., is a renowned leader in the field of movement disorders, Full Professor at the Sackler Faculty of Medicine at Tel Aviv University and chairman of the Neurological Institute at the Tel Aviv Sourasky Medical Center.

His research interests are in the field of gait, falls, cognition and genetics in Parkinson's Disease (PD). Over the past two decades, Prof. Giladi has devoted much of his time to research regarding unique aspects of gait, the prodromal stage of PD, focusing on biological markers of early detection and predicting the conversion from a subject at risk to a patient with PD. He has been leading various large-scale research endeavors to clinically and epidemiologically characterize the Ashkenazi Jewish Parkinson’s Disease population in Israel and to identify genes that influence the risk of developing the disease in this population. He has also been involved in exploring new interventions for patients with PD and in clinical trials phase 1-4 with new technologies treating movement disorders of different kinds as well as community-based epidemiological studies. Giladi and his clinical and research groups are focused on two major goals: a strive to give the best neurological care possible to the patients in there care and to find a cure for Parkinson's disease.

Karen B. Avraham, Ph.D., is Vice Dean and Full Professor at the Sackler Faculty of Medicine and holds the Drs. Sarah and Felix Dumont Chair for Research of Hearing Disorders. She performs research on the genomics of deafness and neurodevelopmental disorders at the Department of Human Molecular Genetics and Biochemistry and is a member of the Sagol School of Neuroscience and the Safra Center for Bioinformatics. Prof. Avraham was awarded the Sir Bernard Katz Prize (Humboldt Foundation, Germany), the Bruno Memorial Prize (Rothschild Foundation), the TEVA Prize for Groundbreaking Research in Rare Diseases, the Teva Founders Prize on Breathroughs and most recently, the Beutler Research Program of Excellence in Genomic Medicine. Her team's grant support is from the National Institute of Health (NIH), Israel Science Foundation (ISF), Israel Precision Medicine Partnership (IPMP) Program, German-Israel Research Foundation (GIF), and Beutler Research Program of Excellence in Genomic Medicine, and to the US-Israel Binational Science Foundation.

Director of the Movement Disorders Institute, Department of Neurology, Chaim Sheba Medical Center Tel-Hashomer, Tel‐Aviv University, Sackler Faculty of Medicine, The Israeli Movement Disorders Society

Department of Neurology, Director of the Movement Disorder Clinic at Rabin Medical Center-Beilinson, The Felsenstein Research Institute, Tel‐Aviv University, Sackler Faculty of Medicine, The Israeli Movement Disorders Society

Director, Parkinson's Disease and Neuroautonomic Service, Movement Disorders Unit at Tel-Aviv Sourasky Medical Center-Ichilov, Tel‐Aviv University, Sackler Faculty of Medicine, The Israeli Movement Disorders Society

Deputy Director of the Neurology Department and Director of the Movement Disorders Clinic at Meir Medical Center in Kfar Saba, The Israeli Movement Disorders Society

Deputy Director of the Neurology Department and Director of the Movement Disorder Clinic at Soroka Medical Center in Beer Sheva, The Israeli Movement Disorders Society

Senior Lecturer, LLD, Department of Nursing and Bioethics and Law Center, Director at the Sackler Faculty of Medicine, Tel-Aviv University. Expert in bioethics, health law and health decision making